Home » Stocks » TMBR

Timber Pharmaceuticals, Inc. (TMBR)

Stock Price: $1.21 USD 0.07 (6.14%)
Updated Jan 25, 2021 4:00 PM EST - Market closed
Market Cap 14.34M
Revenue (ttm) 458,458
Net Income (ttm) n/a
Shares Out 18.89M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $1.21
Previous Close $1.14
Change ($) 0.07
Change (%) 6.14%
Day's Open 1.19
Day's Range 1.12 - 1.38
Day's Volume 12,882,698
52-Week Range 0.26 - 4.11

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 7 hours ago

Dr. Mendelsohn has 20+ Years' Experience in Clinical Development and Medical Affairs

GlobeNewsWire - 1 week ago

Timber Expects to Submit Investigational New Drug (IND) Application to the FDA in 2022

GlobeNewsWire - 1 month ago

Call to be held on Thursday, December 17th at 11:00am EST

GlobeNewsWire - 1 month ago

Presentation on Tuesday December 15th  at 10:40am EST

Benzinga - 1 year ago

Biopharmx Corp shares spiked higher Tuesday morning after the company announced its Phase 2b trial of BPX-04 for Populopustular Rosacea has met both primary and secondary endpoints and was wel...

About TMBR

Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.

Industry
Biotechnology
Founded
2019
Stock Exchange
NYSEAMERICAN
Ticker Symbol
TMBR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for TMBR is 2.25, which is an increase of 85.95% from the latest price.

Price Target
$2.25
(85.95% upside)